NCT03667404View on ClinicalTrials.gov

Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

March 31, 2026

Conditions
Parkinson DiseaseIntestinal Bacteria Flora DisturbanceDietary Modification
Interventions
DIETARY_SUPPLEMENT

Resistant maltodextrin

Resistant maltodextrin powder

DIETARY_SUPPLEMENT

maltodextrin

maltodextrin powder

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
collaborator

University of Illinois at Chicago

OTHER

lead

Northwestern University

OTHER

NCT03667404 - Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study | Biotech Hunter | Biotech Hunter